Search research articles
Contact Us
Filters
Showing results (41-50 of 265) with videos related to
Page
of 27
Sort By:
Disease Markers
|
September 9, 2015
The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
Veronica Villani, Beatrice Casini, Andrea Pace, et al.
Cancer Investigation
|
November 30, 2004
Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients
Paola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Cancers
|
May 28, 2022
T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer
Thibaut Sanglier, Alessandra Fabi, Carlos Flores, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
Antonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 8, 2009
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
Marta Maschio, Loredana Dinapoli, Antonello Vidiri, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
December 19, 2012
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study
Marta Maschio, Loredana Dinapoli, Francesca Sperati, et al.
Journal of Neuro-Oncology
|
July 10, 2008
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy
Marta Maschio, Fiorenzo Albani, Bruno Jandolo, et al.
Eclinicalmedicine
|
January 30, 2023
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
Luca Mastrantoni, Armando Orlandi, Antonella Palazzo, et al.
Oncoimmunology
|
April 9, 2016
Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation
Angela Maselli, Sara Capoccia, Patrizia Pugliese, et al.
The Oncologist
|
September 26, 2025
Validation of the FACIT-Fatigue scale in patients with locally advanced or metastatic breast cancer
Alessandra Fabi, Steven Hager, Laura Lourdes, et al.
Page
of 27
Search research articles
Search
Showing results (41-50 of 265) with videos related to
Sort By:
Page
of 27
Disease Markers
|
September 9, 2015
The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
Veronica Villani, Beatrice Casini, Andrea Pace, et al.
Cancer Investigation
|
November 30, 2004
Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients
Paola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Cancers
|
May 28, 2022
T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer
Thibaut Sanglier, Alessandra Fabi, Carlos Flores, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
Antonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 8, 2009
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
Marta Maschio, Loredana Dinapoli, Antonello Vidiri, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
December 19, 2012
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study
Marta Maschio, Loredana Dinapoli, Francesca Sperati, et al.
Journal of Neuro-Oncology
|
July 10, 2008
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy
Marta Maschio, Fiorenzo Albani, Bruno Jandolo, et al.
Eclinicalmedicine
|
January 30, 2023
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
Luca Mastrantoni, Armando Orlandi, Antonella Palazzo, et al.
Oncoimmunology
|
April 9, 2016
Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation
Angela Maselli, Sara Capoccia, Patrizia Pugliese, et al.
The Oncologist
|
September 26, 2025
Validation of the FACIT-Fatigue scale in patients with locally advanced or metastatic breast cancer
Alessandra Fabi, Steven Hager, Laura Lourdes, et al.
Page
of 27